We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+10.85%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$37.6B
AUM Growth
+$4.89B
(+15%)
Cap. Flow
+$2.25B
Cap. Flow
% of AUM
5.98%
Top 10 Holdings %
Top 10 Hldgs %
23.7%
Holding
2,051
New
98
Increased
1,226
Reduced
674
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$202M |
| 2 |
Linde
LIN
|
+$201M |
| 3 |
Apple
AAPL
|
+$192M |
| 4 |
NVIDIA
NVDA
|
+$187M |
| 5 |
Fastenal
FAST
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WBA
Walgreens Boots Alliance
WBA
|
+$163M |
| 2 |
IBM
IBM
|
+$38.3M |
| 3 |
Target
TGT
|
+$35M |
| 4 |
Sherwin-Williams
SHW
|
+$33.8M |
| 5 |
S&P Global
SPGI
|
+$32.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.52% |
| 2 | Industrials | 11.95% |
| 3 | Consumer Staples | 11.58% |
| 4 | Consumer Discretionary | 9.61% |
| 5 | Financials | 9.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Ascendis Pharma A/S
ASND
$16.7B
| $608K | ﹤0.01% |
4,025
+361
| +10% | +$51.5K |
|
|
SWAV
977
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $608K | ﹤0.01% |
1,868
-150
| -7% | -$36.8K |
|
978
Guardant Health
GH
$19.5B
| $605K | ﹤0.01% |
29,317
+2,518
| +9% | +$54K |
|
979
W.P. Carey
WPC
$17.1B
| $602K | ﹤0.01% |
10,672
-830
| -7% | -$49.7K |
|
980
Gaming and Leisure Properties
GLPI
$12.8B
| $600K | ﹤0.01% |
13,027
-1,018
| -7% | -$46.8K |
|
981
Celsius Holdings
CELH
$6.93B
| $600K | ﹤0.01% |
7,234
-560
| -7% | -$38.4K |
|
982
Rhythm Pharmaceuticals
RYTM
$7B
| $598K | ﹤0.01% |
13,808
+1,527
| +12% | +$66.8K |
|
983
RadNet
RDNT
$4.84B
| $596K | ﹤0.01% |
12,252
+940
| +8% | +$37.9K |
|
984
US Foods
USFD
$21.4B
| $596K | ﹤0.01% |
11,035
-863
| -7% | -$42.5K |
|
985
Roivant Sciences
ROIV
$25.2B
| $595K | ﹤0.01% |
56,474
+5,108
| +10% | +$55.1K |
|
986
CareTrust REIT
CTRE
$10.2B
| $595K | ﹤0.01% |
24,411
+5,181
| +27% | +$117K |
|
987
Sterling Infrastructure
STRL
$20.3B
| $594K | ﹤0.01% |
5,384
+424
| +9% | +$38.5K |
|
988
Axos Financial
AX
$5.45B
| $592K | ﹤0.01% |
10,948
+612
| +6% | +$32.2K |
|
989
First Bancorp
FBP
$4.4B
| $591K | ﹤0.01% |
33,708
+1,396
| +4% | +$23.2K |
|
|
NARI
990
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $591K | ﹤0.01% |
12,319
+553
| +5% | +$29.5K |
|
991
Cactus
WHD
$3.83B
| $590K | ﹤0.01% |
11,779
+1,072
| +10% | +$47.5K |
|
992
Albany International
AIN
$2.14B
| $590K | ﹤0.01% |
6,308
+433
| +7% | +$39.7K |
|
993
MYR Group
MYRG
$5.9B
| $587K | ﹤0.01% |
3,322
+229
| +7% | +$35.2K |
|
|
INBX
994
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $585K | ﹤0.01% |
16,741
+8,033
| +92% | +$293K |
|
|
ARCH
995
DELISTED
Arch Resources, Inc.
ARCH
| $585K | ﹤0.01% |
3,639
+658
| +22% | +$112K |
|
|
ENV
996
DELISTED
ENVESTNET, INC.
ENV
| $585K | ﹤0.01% |
10,095
+693
| +7% | +$36.2K |
|
997
Genworth Financial
GNW
$3.8B
| $584K | ﹤0.01% |
90,792
+4,245
| +5% | +$26.6K |
|
998
Werner Enterprises
WERN
$2.54B
| $583K | ﹤0.01% |
14,913
+659
| +5% | +$26.3K |
|
999
Interactive Brokers
IBKR
$40.9B
| $583K | ﹤0.01% |
20,888
-1,632
| -7% | -$40.6K |
|
1000
Innovative Industrial Properties
IIPR
$1.78B
| $583K | ﹤0.01% |
5,633
+386
| +7% | +$36.8K |
|
Similar funds
ProShare Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, ProShare Advisors held 2,051 positions worth $37.6B, up 15% from $32.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
ProShare Advisors deployed $2.25B of net new capital in Q1 2024, opening 98 new positions and adding to 1,226 existing holdings. Its largest new stake was SS&C Technologies: 123,548 shares worth $7.95M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Industrials and Consumer Staples.
On the sell side, the largest reduction was Walgreens Boots Alliance, an estimated $163M trimmed.
- ProShare Advisors's largest Q1 2024 buy was SS&C Technologies: 123,548 shares worth $7.95M.
- ProShare Advisors added most to Microsoft in Q1 2024, an estimated $202M increase.
- ProShare Advisors's biggest Q1 2024 reduction was Walgreens Boots Alliance, cutting an estimated $163M.
- ProShare Advisors fully exited Splunk Inc in Q1 2024, selling an estimated $20.4M.
- ProShare Advisors's ten largest holdings make up 24% of its $37.6B portfolio in Q1 2024.
- ProShare Advisors opened 98 new positions and closed 47 in Q1 2024.
- ProShare Advisors's portfolio value rose 15% quarter-over-quarter to $37.6B.
Based on ProShare Advisors's 13F filing for Q1 2024, filed 8 May 2024.